Ehdn Platform Meeting Tominersen Generation Hd2 Results And Key Learnings

Summary

After several months digging into all the information collected in the On March 29, 2021, Roche presented the data that led to the decision to halt dosing of KEYNOTE LECTURE: Huntington's Disease Now – Mechanisms and Therapeutics Chaired by Alexandra Durr Speaker: Sarah ... UPDATE ON ONGOING CLINICAL TRAILS Chaired by Ahmad Aziz and Tiago Mestre 1. SOM Biotech Raul Insta 2. Prilenia ... The European Huntington Association, in collaboration with Roche, organized a webinar to discuss updates on the During this Webinar of May Awareness Month 2021 (6th of May), Lauren Boak from ROCHE spoke about the preliminary analysis ... UK researchers announced a breakthrough gene therapy that slowed Huntington's disease for the first time. Early-stage trials at ... DMD (Duchenne muscular dystrophy) is an X-linked progressive muscle-wasting disorder caused by mutations in the dystrophin ... Join us for the Royal Society Ferrier Prize Lecture delivered by Professor Gillian Bates FRS. Professor Gillian Bates FRS is ... Ionis partner Roche will evaluate Thommassen's treatment of Huntington's disease in a new phase II trial Ionis Pharmaceuticals ...